Global Yellow Fever Treatment Market, by Transmission Type (Sylvatic Yellow Fever, Intermediate Yellow Fever, and Urban Yellow Fever), by Treatment Type (Vaccines, Medications, and Others), by Application (Hospitals, Clinics, Community Health Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 470.5 Mn in 2021 and is expected to exhibit a CAGR of 3.7% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Increasing research and development to produce a new vaccine for yellow fever is expected to propel the growth of the global yellow fever treatment market over the forecast period. For instance, in July 2021, Saint Louis University’s Center for Vaccine Development started studying an investigational vaccine for yellow fever. The research was funded by Sanofi Pasteur. A new vaccine for yellow fever is highly needed as the current vaccine contains egg protein and hence cannot be used by people with egg allergies. Yellow fever vaccination is required for travelers and military personnel, especially with countries where there is a prevalence of yellow fever virus.
Global Yellow Fever Treatment Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic has greatly impacted clinical trials. Various trials have been paused, and researchers are facing a lot of challenges associated with setting up remote visits and performing necessary laboratory and other study assessments.
The major challenges include the supply of raw materials for manufacturing drugs due to disruptions in transportation.
COVID-19 continues to cause considerable medical unattendance. As in other countries in the world, such as Brazil, India, and Pakistan, the coronavirus disease 2019 (COVID-19) outbreak had a negative impact on preventive measures against vector-borne infectious diseases on the African continent, inflicting critical postponements. Decreased routine vaccination coverage in 2020 without vaccination might cause an increase in measles and yellow fever disease burden.
Browse 28 Market Data Tables and 23 Figures spread through 191 Pages and an in-depth TOC on “Global Yellow Fever Treatment Market”- Forecast to 2028, Global Yellow Fever Treatment Market, by Transmission Type (Sylvatic Yellow Fever, Intermediate Yellow Fever, and Urban Yellow Fever), by Treatment Type (Vaccines, Medications, and Others), by Application (Hospitals, Clinics, Community Health Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the Global Yellow Fever Treatment Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/yellow-fever-treatment-market-4774
Moreover, the support of various organizations to vaccinate large number of people is also driving the growth of the global yellow fever treatment market over the forecast period. For instance, the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunization), a global health partnership of public and private sector organizations is dedicated to “immunization for all”, aiming to protect lives by increasing vaccination and trying to immunize everyone. Since 2001, the alliance has invested more than US$ 500 million in yellow fever to control the spread. It’s focus is specifically on the African countries where the majority of deaths occur due to yellow fever. The Vaccine Alliance funds routine vaccines. Due to the continued risk of outbreaks, coupled with the improved supply situation for the vaccine, Nigeria resumed its yellow fever vaccination campaign in 2017, continuing with Gavi-supported phases in 2019-2021.
Key Takeaways of the Global Yellow Fever Treatment Market:
- The global yellow fever treatment market is expected to exhibit a CAGR of 3.7% during the forecast period due to increasing strategies and rising research and development. For instance, in 2017, the Eliminate Yellow fever Epidemics (EYE) Strategy was launched. It was an unprecedented initiative. With more than 50 partners involved, the EYE partnership supports about 40 countries that are at risk in Africa and America. It aims to detect, prevent, and respond to yellow fever suspected cases and outbreaks. The collaboration aims to protect populations that are at risk and prevent its international spread. It is expected that by 2026, more than 1 billion people will be protected from this disease.
- Among regions, North America is expected to hold a dominant position in the global yellow fever treatment market over the forecast period. Factors such as the rise in prevalence of yellow fever, expansion of the healthcare industry, and rising government investment to develop healthcare infrastructure are believed to attribute majorly to the global yellow fever treatment market growth.
- Major players operating in the yellow fever treatment market include Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos, Institut Pasteur de Dakar, and FSUE Chumakov
